Genelux Ownership 2024 | Who Owns Genelux Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

16.29%

Institutional Holders

21.00

Genelux Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.--14,50114,501100.00%402,257,000Mar 31, 2023
BARCLAYS PLC-0.00%33,17833,178100.00%920,000Mar 31, 2023
MORGAN STANLEY--1,9841,984100.00%55,036,000Mar 31, 2023
CITADEL ADVISORS LLC-0.00%10,61510,615100.00%294,460,000Mar 31, 2023
UBS GROUP AG--184184100.00%5,104,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.-0.00%1,0011,001100.00%27,768,000Mar 31, 2023
ROYAL BANK OF CANADA--2,0002,000100.00%55,000,000Mar 31, 2023
JPMORGAN CHASE & CO--100100100.00%3,000,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--1,0181,018100.00%28,239,000Mar 31, 2023
ALLWORTH FINANCIAL LP--162162100.00%4,494,000Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC-0.00%15,17615,176100.00%420,982,000Mar 31, 2023
NORTHERN TRUST CORP-0.00%11,18511,185100.00%310,272,000Mar 31, 2023
CITIGROUP INC-0.00%3,0313,031100.00%84,080,000Mar 31, 2023
STATE STREET CORP--7,7007,700100.00%213,598,000Mar 31, 2023
GOLDMAN SACHS GROUP INC-0.00%8,6478,647100.00%239,868,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%1,1471,147100.00%32,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC-0.00%37,70937,709100.00%1,046,047,000Mar 31, 2023
VANGUARD GROUP INC--67,65867,658100.00%1,876,832,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC-0.00%8,7638,763100.00%243,000Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC-0.36%44,94044,940100.00%1,246,636,000Mar 31, 2023

Genelux's largest institutional shareholder is BLACKROCK INC., holding 0.00% of the company's total share outstanding, currently valued at $402.26M. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HOHIMER WEALTH MANAGEMENT, LLC-0.36%44,94044,940100.00%1,246,636,000Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC-0.04%16,66816,668100.00%462,370,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%1,1471,147100.00%32,000Mar 31, 2023
BARCLAYS PLC-0.00%33,17833,178100.00%920,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC-0.00%8,7638,763100.00%243,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC-0.00%37,70937,709100.00%1,046,047,000Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC-0.00%15,17615,176100.00%420,982,000Mar 31, 2023
CITADEL ADVISORS LLC-0.00%10,61510,615100.00%294,460,000Mar 31, 2023
NORTHERN TRUST CORP-0.00%11,18511,185100.00%310,272,000Mar 31, 2023
CITIGROUP INC-0.00%3,0313,031100.00%84,080,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.-0.00%1,0011,001100.00%27,768,000Mar 31, 2023
GOLDMAN SACHS GROUP INC-0.00%8,6478,647100.00%239,868,000Mar 31, 2023
VANGUARD GROUP INC--67,65867,658100.00%1,876,832,000Mar 31, 2023
ALLWORTH FINANCIAL LP--162162100.00%4,494,000Mar 31, 2023
ROYAL BANK OF CANADA--2,0002,000100.00%55,000,000Mar 31, 2023
STATE STREET CORP--7,7007,700100.00%213,598,000Mar 31, 2023
BLACKROCK INC.--14,50114,501100.00%402,257,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--1,0181,018100.00%28,239,000Mar 31, 2023
MORGAN STANLEY--1,9841,984100.00%55,036,000Mar 31, 2023
UBS GROUP AG--184184100.00%5,104,000Mar 31, 2023

The largest Genelux shareholder by % of total assets is HOHIMER WEALTH MANAGEMENT, LLC. The company owns 44.94K shares of Genelux (GNLX), representing 0.36% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC--67,65867,658100.00%1,876,832,000Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC-0.36%44,94044,940100.00%1,246,636,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC-0.00%37,70937,709100.00%1,046,047,000Mar 31, 2023
BARCLAYS PLC-0.00%33,17833,178100.00%920,000Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC-0.04%16,66816,668100.00%462,370,000Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC-0.00%15,17615,176100.00%420,982,000Mar 31, 2023
BLACKROCK INC.--14,50114,501100.00%402,257,000Mar 31, 2023
NORTHERN TRUST CORP-0.00%11,18511,185100.00%310,272,000Mar 31, 2023
CITADEL ADVISORS LLC-0.00%10,61510,615100.00%294,460,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC-0.00%8,7638,763100.00%243,000Mar 31, 2023
GOLDMAN SACHS GROUP INC-0.00%8,6478,647100.00%239,868,000Mar 31, 2023
STATE STREET CORP--7,7007,700100.00%213,598,000Mar 31, 2023
CITIGROUP INC-0.00%3,0313,031100.00%84,080,000Mar 31, 2023
ROYAL BANK OF CANADA--2,0002,000100.00%55,000,000Mar 31, 2023
MORGAN STANLEY--1,9841,984100.00%55,036,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%1,1471,147100.00%32,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--1,0181,018100.00%28,239,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.-0.00%1,0011,001100.00%27,768,000Mar 31, 2023
UBS GROUP AG--184184100.00%5,104,000Mar 31, 2023
ALLWORTH FINANCIAL LP--162162100.00%4,494,000Mar 31, 2023

As of Mar 31 2023, Genelux's largest institutional buyer is VANGUARD GROUP INC. The company purchased 67.66K stocks of GNLX, valued at $1.88B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO--100100100.00%3,000,000Mar 31, 2023
ALLWORTH FINANCIAL LP--162162100.00%4,494,000Mar 31, 2023
UBS GROUP AG--184184100.00%5,104,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.-0.00%1,0011,001100.00%27,768,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--1,0181,018100.00%28,239,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%1,1471,147100.00%32,000Mar 31, 2023
MORGAN STANLEY--1,9841,984100.00%55,036,000Mar 31, 2023
ROYAL BANK OF CANADA--2,0002,000100.00%55,000,000Mar 31, 2023
CITIGROUP INC-0.00%3,0313,031100.00%84,080,000Mar 31, 2023
STATE STREET CORP--7,7007,700100.00%213,598,000Mar 31, 2023
GOLDMAN SACHS GROUP INC-0.00%8,6478,647100.00%239,868,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC-0.00%8,7638,763100.00%243,000Mar 31, 2023
CITADEL ADVISORS LLC-0.00%10,61510,615100.00%294,460,000Mar 31, 2023
NORTHERN TRUST CORP-0.00%11,18511,185100.00%310,272,000Mar 31, 2023
BLACKROCK INC.--14,50114,501100.00%402,257,000Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC-0.00%15,17615,176100.00%420,982,000Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC-0.04%16,66816,668100.00%462,370,000Mar 31, 2023
BARCLAYS PLC-0.00%33,17833,178100.00%920,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC-0.00%37,70937,709100.00%1,046,047,000Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC-0.36%44,94044,940100.00%1,246,636,000Mar 31, 2023

As of Mar 31 2023, Genelux's biggest institutional seller is JPMORGAN CHASE & CO. The company sold 100.00 shares of GNLX, valued at $3.00M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC--67,65867,658100.00%1,876,832,000Mar 31, 2023
HOHIMER WEALTH MANAGEMENT, LLC-0.36%44,94044,940100.00%1,246,636,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC-0.00%37,70937,709100.00%1,046,047,000Mar 31, 2023
BARCLAYS PLC-0.00%33,17833,178100.00%920,000Mar 31, 2023
AXXCESS WEALTH MANAGEMENT, LLC-0.04%16,66816,668100.00%462,370,000Mar 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC-0.00%15,17615,176100.00%420,982,000Mar 31, 2023
BLACKROCK INC.--14,50114,501100.00%402,257,000Mar 31, 2023
NORTHERN TRUST CORP-0.00%11,18511,185100.00%310,272,000Mar 31, 2023
CITADEL ADVISORS LLC-0.00%10,61510,615100.00%294,460,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC-0.00%8,7638,763100.00%243,000Mar 31, 2023
GOLDMAN SACHS GROUP INC-0.00%8,6478,647100.00%239,868,000Mar 31, 2023
STATE STREET CORP--7,7007,700100.00%213,598,000Mar 31, 2023
CITIGROUP INC-0.00%3,0313,031100.00%84,080,000Mar 31, 2023
ROYAL BANK OF CANADA--2,0002,000100.00%55,000,000Mar 31, 2023
MORGAN STANLEY--1,9841,984100.00%55,036,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%1,1471,147100.00%32,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--1,0181,018100.00%28,239,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.-0.00%1,0011,001100.00%27,768,000Mar 31, 2023
UBS GROUP AG--184184100.00%5,104,000Mar 31, 2023
ALLWORTH FINANCIAL LP--162162100.00%4,494,000Mar 31, 2023
JPMORGAN CHASE & CO--100100100.00%3,000,000Mar 31, 2023

Genelux's largest new institutional shareholder by number of shares is VANGUARD GROUP INC, purchased 67.66K shares, valued at $1.88B, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Genelux Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.03%13,500--Mar 31, 2024
Humankind Benefit Corp0.02%44720584.71%Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%51,982--Jan 31, 2024
ETF Series Solutions0.00%7,2941,16819.07%Feb 29, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%10,341--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%6,408-1,115-14.82%Mar 31, 2024
Global X Funds0.00%8,772--Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.00%851851-Mar 28, 2024
NORTHERN FUNDS0.00%10,496-973-8.48%Mar 28, 2024
RYDEX SERIES FUNDS0.00%169--Dec 31, 2023
Goldman Sachs ETF Trust0.00%3,925--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%84--Dec 31, 2023
PENN SERIES FUNDS INC0.00%600--Mar 28, 2024
SEASONS SERIES TRUST0.00%470--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%2,16190.42%Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%2,60173139.09%Jan 31, 2024
RYDEX VARIABLE TRUST0.00%11--Dec 31, 2023
TIAA-CREF FUNDS0.00%25,2246,65935.87%Jan 31, 2024
Brighthouse Funds Trust II0.00%6,436--Mar 31, 2024
SUNAMERICA SERIES TRUST0.00%2,102-9-0.43%Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%7,378--Mar 31, 2024
Advisors' Inner Circle Fund III0.00%6262-Jan 31, 2024
BLACKROCK FUNDS0.00%2,964--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%2,223-225-9.19%Jan 31, 2024
iSHARES TRUST0.00%5,492-726,364-99.25%Mar 31, 2024

Genelux's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 13.50K shares, compromising 0.03% of its total assets.

Genelux Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2321-

As of 31 Mar 23, 21 institutions are holding Genelux's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 23287,367-

Genelux (GNLX) has 287.37K shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 23--

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2321-287,367-------

Genelux Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 08, 2024Yu Yongofficer VP, Clinical Trial OperationsS-SaleSell6,849$2.12$14.52K10,869

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 08, 2024Yu Yongofficer VP, Clinical Trial OperationsS-SaleSell6,849$2.12$14.52K10,869

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 05, 2024Tyree James Ldirector-A-AwardBuy50,469$1.54$77.72K50,469
Aug 05, 2024Tyree James Ldirector-A-AwardBuy39,541--49,251
Aug 05, 2024Mirabelli Marydirector-A-AwardBuy39,541--52,001
Aug 05, 2024Mirabelli Marydirector-A-AwardBuy50,469$1.54$77.72K50,469
Aug 05, 2024Thomas Johndirector-A-AwardBuy39,541--505,501
Aug 05, 2024Thomas Johndirector-A-AwardBuy50,469$1.54$77.72K50,469
Aug 05, 2024Smither John Wdirector-A-AwardBuy39,541--52,711
Aug 05, 2024Smither John Wdirector-A-AwardBuy50,469$1.54$77.72K50,469
Jul 08, 2024Zindrick Thomasdirector, officer President and CEOA-AwardBuy26,264--50,207
Jul 08, 2024Zindrick Thomasdirector, officer President and CEOA-AwardBuy8,320--22,971
Jul 08, 2024Zak Lourie S.officer Chief Financial OfficerA-AwardBuy3,852--38,428
Jul 08, 2024Zak Lourie S.officer Chief Financial OfficerA-AwardBuy1,220--32,470
Jul 08, 2024Smalling Ralphofficer Head of RegulatoryA-AwardBuy2,107--18,144
Jul 08, 2024Smalling Ralphofficer Head of RegulatoryA-AwardBuy616--13,931
Jul 08, 2024Cappello Josephofficer VP, Pharmaceutical DevelopmentA-AwardBuy11,557--20,953
Jul 08, 2024Cappello Josephofficer VP, Pharmaceutical DevelopmentA-AwardBuy3,661--9,396
Jul 08, 2024Yu Yongofficer VP, Clinical Trial OperationsA-AwardBuy11,557--17,718
Jul 08, 2024Yu Yongofficer VP, Clinical Trial OperationsS-SaleSell6,849$2.12$14.52K10,869
Jul 08, 2024Yu Yongofficer VP, Clinical Trial OperationsA-AwardBuy3,661--6,161
Jul 08, 2024Ryder Seanofficer General CounselA-AwardBuy9,270--22,778

The last insider sell of Genelux's stock was made by Yu Yong on Jul 08 2024, selling 6,849 shares at $2.12 per share (valued at $14.52K).

Genelux Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-13-
Q4 202332213.64%
Q3 2023225540.00%
Q2 2023-2-
Q1 20231717100.00%

0 total buy trades, and 13 total sell trades (buy/sell ratio of 0.00%) were made by Genelux's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-13-
Q4 2023-20-
Q3 2023-50-
Q2 2023---
Q1 20231--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 13 open market sell trades of Genelux's stocks.

Genelux Peer Ownership


TickerCompany
DYAIDyadic International, Inc.
CGEMCullinan Oncology, Inc.
MNPRMonopar Therapeutics Inc.
IVAInventiva S.A.
CNTACentessa Pharmaceuticals plc
IKNAIkena Oncology, Inc.
LRMRLarimar Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
CINGCingulate Inc.
TERNTerns Pharmaceuticals, Inc.
MLTXMoonLake Immunotherapeutics
GLUEMonte Rosa Therapeutics, Inc.
ABOSAcumen Pharmaceuticals, Inc.
NAMSNewAmsterdam Pharma Company N.V.
IMRXImmuneering Corporation
CELCCelcuity Inc.
CMPXCompass Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals, Inc.

GNLX Ownership FAQ


Genelux is owned by institutional shareholders (0%), insiders (16.29%), and public (0%). The largest institutional shareholder of Genelux is BLACKROCK INC. (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).

Genelux's major institutional shareholders are BLACKROCK INC., BARCLAYS PLC, MORGAN STANLEY, CITADEL ADVISORS LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2023, there are 21 institutional shareholders of Genelux.

BLACKROCK INC owns 14.5K shares of Genelux, representing 0% of the company's total shares outstanding, valued at $402.26M (as of Mar 2023).

As of Mar 2023, BARCLAYS PLC holds 33.18K shares of Genelux (GNLX), compromising 0% of the company, valued at $920K.

MORGAN STANLEY is the third largest holder of Genelux. The company owns 1.98K of the company's shares outstanding (worth $55.04M).